DK0456183T3 - Spiro-dibenzosuberan-derivater - Google Patents

Spiro-dibenzosuberan-derivater

Info

Publication number
DK0456183T3
DK0456183T3 DK91107396.3T DK91107396T DK0456183T3 DK 0456183 T3 DK0456183 T3 DK 0456183T3 DK 91107396 T DK91107396 T DK 91107396T DK 0456183 T3 DK0456183 T3 DK 0456183T3
Authority
DK
Denmark
Prior art keywords
alkyl
hydrogen
derivatives
dibenzosuberane
spiro
Prior art date
Application number
DK91107396.3T
Other languages
Danish (da)
English (en)
Inventor
Hiromu Matsumura
Hiroshi Hashizume
Masami Eigyo
Makoto Adachi
Toshisada Yano
Akira Matsushita
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0456183T3 publication Critical patent/DK0456183T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK91107396.3T 1990-05-07 1991-05-07 Spiro-dibenzosuberan-derivater DK0456183T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11812690 1990-05-07

Publications (1)

Publication Number Publication Date
DK0456183T3 true DK0456183T3 (da) 1995-11-20

Family

ID=14728685

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91107396.3T DK0456183T3 (da) 1990-05-07 1991-05-07 Spiro-dibenzosuberan-derivater

Country Status (10)

Country Link
EP (1) EP0456183B1 (fr)
JP (1) JPH04225953A (fr)
KR (1) KR910019978A (fr)
AT (1) ATE128705T1 (fr)
CA (1) CA2040750A1 (fr)
DE (1) DE69113505T2 (fr)
DK (1) DK0456183T3 (fr)
ES (1) ES2080182T3 (fr)
GR (1) GR3017868T3 (fr)
HU (1) HUT58057A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538986A (en) * 1993-12-06 1996-07-23 Schering Corporation Tricyclic derivatives, compositions and methods of use
US5760246A (en) * 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
UA73749C2 (en) * 1999-11-01 2005-09-15 Diarylenines
ES2315494T3 (es) * 2002-04-26 2009-04-01 Schering Corporation Antagonistas muscarinicos.
US7101917B2 (en) * 2003-04-14 2006-09-05 Hoffmann-La Roche Inc. Mitochrondrial permeability transition pore affinity labels and modulators
AU2004233863B2 (en) 2003-04-24 2010-06-17 Incyte Holdings Corporation Aza spiro alkane derivatives as inhibitors of metalloproteases
BRPI0607768A2 (pt) * 2005-02-25 2009-10-06 Irm Llc compostos e composições contendo espiro como moduladores de receptores nucleares de hormÈnios esteróides, método para a preparação dos referidos compostos, usos relacionados, bem como métodos para modular a atividade de no mìnimo um receptor nuclear de hormÈnios esteróides
WO2012169014A1 (fr) 2011-06-07 2012-12-13 パイオニア株式会社 Dispositif d'appariement d'impédance et procédé de contrôle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719199D0 (en) * 1987-08-13 1987-09-23 Merck Sharp & Dohme Chemical compounds

Also Published As

Publication number Publication date
EP0456183B1 (fr) 1995-10-04
HUT58057A (en) 1992-01-28
HU911520D0 (en) 1991-11-28
EP0456183A3 (en) 1992-04-22
ES2080182T3 (es) 1996-02-01
ATE128705T1 (de) 1995-10-15
GR3017868T3 (en) 1996-01-31
EP0456183A2 (fr) 1991-11-13
DE69113505T2 (de) 1996-04-04
JPH04225953A (ja) 1992-08-14
CA2040750A1 (fr) 1991-11-08
DE69113505D1 (de) 1995-11-09
KR910019978A (ko) 1991-12-19

Similar Documents

Publication Publication Date Title
BR9004698A (pt) Derivados de 4-benzoil-isoxazol
ES2048109B1 (es) Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
EE200000059A (et) Tetrahüdro-gamma-karboliinid
DK0456183T3 (da) Spiro-dibenzosuberan-derivater
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
DE69623497D1 (de) 1-methylcarbapenem-derivate
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
ES2019554A6 (es) Procedimiento para preparar n,n -ditrimetoxibenzoilpiperazinas sustituidas en posicion 2"
NO910904L (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
FI956151A (fi) Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia
DK0420224T3 (da) Anthihepatopatisk middel
EP1112998A4 (fr) Derives d'amine
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
ATE103490T1 (de) Derivate der p-guanidinobenzoesaeure zur behandlung der zerebrovaskulaeren kontraktion.
ATE100449T1 (de) 1,3-dioxolan-benzoesaeure und derivate davon.